title,url,time_published,summary,ticker,relevance_score,ticker_sentiment_score,ticker_sentiment_label
Revvity  ( RVTY )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2215914/revvity-rvty-to-report-q4-earnings-whats-in-the-cards,2024-01-25 15:19:00,"Revvity's (RVTY) fourth-quarter results are likely to reflect weak performance at the Diagnostics segment, partially offset by strong demand for its Life Sciences and Diagnostics franchises.",RVTY,0.445569,0.071098,Neutral
"Next Generation Sequencers  ( NGS )  Market Set to Surge at 8.3% CAGR, to Reach USD 2.4 billion by 2031 | Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/24/01/g36612730/next-generation-sequencers-ngs-market-set-to-surge-at-8-3-cagr-to-reach-usd-2-4-billion-by-2031-tr,2024-01-12 15:45:48,"Wilmington, Delaware, United States, Jan. 12, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The next generation sequencers ( NGS ) industry was valued at US$ 1.2 billion in 2022. A CAGR of 8.3% is projected between 2023 and 2031, and the market will reach over US$ 2.4 billion by ...",RVTY,0.034332,0.236591,Somewhat-Bullish
"Biochemical & sequencing testing combination to be most comprehensive approach to newborn's proactive health: Madhuri Hedge, Senior Vice President, Revvity",https://www.financialexpress.com/healthcare/diagnostic/biochemical-sequencing-testing-combination-to-be-most-comprehensive-approach-to-newborns-proactive-health-madhuri-hedge-senior-vice-president-revvity/3336581/,2023-12-12 10:40:24,"Genome sequencing, a revolutionary scientific advancement, has transformed our understanding of life at its most fundamental level. At its core, genome sequencing involves decoding the complete set of genetic instructions within an organism's DNA, unraveling the intricacies of its genetic code.",RVTY,0.17715,0.199604,Somewhat-Bullish
Revvity  ( RVTY )  Launches New Molecular Testing for Newborns,https://www.zacks.com/stock/news/2192024/revvity-rvty-launches-new-molecular-testing-for-newborns,2023-12-01 12:47:00,"Revvity's (RVTY) EONIS Q System is set to transform SMA and SCID testing, advancing global healthcare for infants.",RVTY,0.469099,0.226677,Somewhat-Bullish
Study Shows that OGM Plays an Important Role in Efficient Diagnosis of FSHD - Bionano Genomics  ( NASDAQ:BNGO ) ,https://www.benzinga.com/pressreleases/23/11/g36020856/study-shows-that-ogm-plays-an-important-role-in-efficient-diagnosis-of-fshd,2023-11-30 13:00:00,"SAN DIEGO, Nov. 30, 2023 ( GLOBE NEWSWIRE ) -- Bionano Laboratories today announced the publication by scientists at Revvity Omics ( formerly Perkin Elmer Genomics ) , Leiden University Medical Centre, Bombay Hospital, and UT Dallas, of the largest peer-reviewed study to date on the use of ...",RVTY,0.041538,0.0,Neutral
Revvity launches screening test for Latent TB Screening in India,https://www.financialexpress.com/healthcare/diagnostic/revvity-launches-screening-test-for-latent-tb-screening-in-india/3319096/,2023-11-28 02:30:00,"Revvity, a Diagnostics and Life Sciences company, recently announced the country launch of its T-SPOT.TB test for latent TB screening, at MICROCON in Lucknow. Revvity's T-SPOT.TB is the only FDA-approved, commercially available IGRA ( interferon-gamma release assay ) based on the ELISPOT ...",RVTY,0.316846,0.076626,Neutral
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Revvity, Inc. - RVTY - Revvity  ( NYSE:RVTY ) ",https://www.benzinga.com/pressreleases/23/11/g35765552/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-revvity-inc-rvt,2023-11-13 22:13:48,"NEW YORK, Nov. 13, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Revvity, Inc. ( ""Revvity"" or the ""Company"" ) RVTY. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",RVTY,0.591019,-0.247827,Somewhat-Bearish
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Revvity, Inc. - RVTY - Revvity  ( NYSE:RVTY ) ",https://www.benzinga.com/pressreleases/23/11/g35611304/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-revvity-inc-rvt,2023-11-05 21:17:28,"NEW YORK, Nov. 05, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Revvity, Inc. ( ""Revvity"" or the ""Company"" ) RVTY. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",RVTY,0.591019,-0.247827,Somewhat-Bearish
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Revvity, Inc. - RVTY",https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-revvity-inc---rvty-301977469.html,2023-11-03 20:47:00,"NEW YORK, Nov. 3, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Revvity, Inc. ( ""Revvity"" or the ""Company"" ) ( NYSE: RVTY ) . Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.",RVTY,0.622414,-0.210795,Somewhat-Bearish
"Company News for Oct 31, 2023",https://www.zacks.com/stock/news/2175253/company-news-for-oct-31-2023,2023-10-31 12:54:00,"Companies in The News Are: HLIT, JKS, RVTY, ON.",RVTY,0.595343,0.100496,Neutral
Why Revvity Stock Plunged Today,https://www.fool.com/investing/2023/10/30/why-revvity-stock-plunged-today/,2023-10-30 21:12:29,Revvity announced disappointing results and lowered its full-year outlook. Here's what investors need to know.,RVTY,0.796885,0.377802,Bullish
"Revvity  ( RVTY )  Misses on Q3 Earnings, Lowers '23 EPS View",https://www.zacks.com/stock/news/2174778/revvity-rvty-misses-on-q3-earnings-lowers-23-eps-view,2023-10-30 15:55:00,Revvity's (RVTY) third-quarter results reflect the impact of increased market uncertainty. The company's earnings and sales miss their respective estimates.,RVTY,0.424521,-0.037178,Neutral
Why Biotechnology Company Revvity's  ( RVTY )  Shares Diving Today - Revvity  ( NYSE:RVTY ) ,https://www.benzinga.com/news/earnings/23/10/35490097/why-biotechnology-company-revvitys-shares-diving-today,2023-10-30 14:12:14,"Revvity Inc RVTY shares are trading lower by around 17% after the company reported worse-than-expected Q3 FY23 results and lowered its FY23 guidance. Revenue declined to $671 million from $712 million a year ago ( organic decline of 7% Y/Y ) , missing the consensus of $695.3 million.",RVTY,0.608634,0.145975,Neutral
Revvity  ( RVTY )  Misses Q3 Earnings and Revenue Estimates,https://www.zacks.com/stock/news/2174247/revvity-rvty-misses-q3-earnings-and-revenue-estimates,2023-10-30 11:15:03,"Revvity (RVTY) delivered earnings and revenue surprises of -0.84% and 3.10%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?",RVTY,0.400265,0.095595,Neutral
"ArcelorMittal, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session",https://markets.businessinsider.com/news/stocks/arcelormittal-and-other-big-stocks-moving-lower-in-monday-s-pre-market-session-1032753490,2023-10-30 10:44:11,"U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today's pre-market trading session. â€¢ Olaplex Holdings, Inc. ( NASDAQ:OLPX ) shares fell 4.8% to $1.38 in pre-market trading after falling around 6% on Friday.",RVTY,0.150592,-0.109293,Neutral
Research Antibodies & Reagents Market is Expected to Reach $16.2 billion | MarketsandMarkets.,https://www.benzinga.com/pressreleases/23/10/g35462628/research-antibodies-reagents-market-is-expected-to-reach-16-2-billion-marketsandmarkets,2023-10-27 12:30:00,"Chicago, Oct. 27, 2023 ( GLOBE NEWSWIRE ) -- The research antibodies and reagents industry is poised for significant growth in the near future, driven by advancing biotechnological research and increasing demand for high-quality tools to support scientific discovery.",RVTY,0.039811,0.0,Neutral
Revvity  ( RVTY )  to Report Q3 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2172958/revvity-rvty-to-report-q3-earnings-whats-in-the-cards,2023-10-26 14:07:00,"Revvity's (RVTY) third-quarter results are likely to reflect weak performance at the Diagnostics segment, partially offset by strong demand for Life Sciences and Diagnostics franchise.",RVTY,0.449503,0.318932,Somewhat-Bullish
Bausch + Lomb  ( BLCO )  Expected to Beat Earnings Estimates: Can the Stock Move Higher?,https://www.zacks.com/stock/news/2171628/bausch-lomb-blco-expected-to-beat-earnings-estimates-can-the-stock-move-higher,2023-10-25 14:02:07,Bausch + Lomb (BLCO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,RVTY,0.175539,-0.011428,Neutral
Analysts Estimate Revvity  ( RVTY )  to Report a Decline in Earnings: What to Look Out for,https://www.zacks.com/stock/news/2170301/analysts-estimate-revvity-rvty-to-report-a-decline-in-earnings-what-to-look-out-for,2023-10-23 14:00:39,Revvity (RVTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,RVTY,0.258808,-0.015929,Neutral
Revvity's  ( RVTY )  New Tie-Up to Boost NGS Research Workflow,https://www.zacks.com/stock/news/2169008/revvitys-rvty-new-tie-up-to-boost-ngs-research-workflow,2023-10-19 15:19:00,Revvity's (RVTY) latest partnership is likely to address the workflow-related challenges faced by labs and democratize genomic sequencing.,RVTY,0.429541,0.481611,Bullish
"Revvity, Inc. and Element Biosciences, Inc. Pioneer Next-Generation Sequencing Kits Market with Innovative Genomic Analysis Solutions",https://www.prnewswire.com/news-releases/revvity-inc-and-element-biosciences-inc-pioneer-next-generation-sequencing-kits-market-with-innovative-genomic-analysis-solutions-301960404.html,2023-10-18 21:15:00,"Revvity, Inc. and Element Biosciences, Inc. Pioneer Next-Generation Sequencing Kits Market with Innovative Genomic ... PR ...",RVTY,0.057079,0.210035,Somewhat-Bullish
"Stocks That Hit 52-Week Lows On Thursday - PRA Group  ( NASDAQ:PRAA ) , Perimeter Solutions  ( NYSE:PRM ) ",https://www.benzinga.com/news/23/10/35111787/stocks-that-hit-52-week-lows-on-thursday,2023-10-05 17:22:02,"On Thursday, 369 companies hit new 52-week lows. The largest company in terms of market cap to set a new 52-week low was Coca-Cola KO. The smallest company by market cap to hit a new 52-week low was Neptune Wellness Solns NEPT.",RVTY,0.013047,-0.097823,Neutral
Revvity's  ( RVTY )  New Launch to Widen Access to Editing Technology,https://www.zacks.com/stock/news/2158739/revvitys-rvty-new-launch-to-widen-access-to-editing-technology,2023-10-02 14:10:00,Revvity's (RVTY) latest offering is likely to improve access to new-generation editing technology and bridge both preclinical and clinical discoveries with the same technology platform.,RVTY,0.305328,0.244962,Somewhat-Bullish
Smarter Science: How Laboratory Automation Is Shaping the Future of Research and Diagnostics,https://www.prnewswire.com/news-releases/smarter-science-how-laboratory-automation-is-shaping-the-future-of-research-and-diagnostics-301936087.html,2023-09-22 22:15:00,"DUBLIN, Sept. 22, 2023 /PRNewswire/ -- The ""Laboratory Automation Market - A Global Market and Regional Analysis: Focus on Product, Application, End User, and Region - Analysis and Forecast, 2023-2033"" report has been added to ResearchAndMarkets.com's offering.",RVTY,0.050359,0.118287,Neutral
Revvity  ( RVTY )  Launches Three New Preclinical Research Systems,https://www.zacks.com/stock/news/2145475/revvity-rvty-launches-three-new-preclinical-research-systems,2023-09-06 13:36:00,Revvity (RVTY) launches new preclinical imaging technologies for breakthrough discoveries. Learn how they can help advance research and boost Revvity's prospect.,RVTY,0.2872,0.304227,Somewhat-Bullish
Revvity  ( RVTY )  Down 4.9% Since Last Earnings Report: Can It Rebound?,https://www.zacks.com/stock/news/2143098/revvity-rvty-down-49-since-last-earnings-report-can-it-rebound,2023-08-31 15:31:30,Revvity (RVTY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,RVTY,0.383765,0.008042,Neutral
Telesis Bio Appoints William J. Kullback Chief Financial Officer - Telesis Bio  ( NASDAQ:TBIO ) ,https://www.benzinga.com/pressreleases/23/08/g34101931/telesis-bio-appoints-william-j-kullback-chief-financial-officer,2023-08-29 20:05:00,"SAN DIEGO, Aug. 29, 2023 ( GLOBE NEWSWIRE ) -- Telesis Bio Inc. TBIO, a leader in automated multi-omic and synthetic biology solutions, has named William J. Kullback as its Chief Financial Officer, effective August 28, 2023.",RVTY,0.072,0.040201,Neutral
Telesis Bio Appoints William J. Kullback Chief Financial Officer,https://www.globenewswire.com/news-release/2023/08/29/2733875/0/en/Telesis-Bio-Appoints-William-J-Kullback-Chief-Financial-Officer.html,2023-08-29 20:05:00,"SAN DIEGO, Aug. 29, 2023 ( GLOBE NEWSWIRE ) -- Telesis Bio Inc. ( NASDAQ: TBIO ) , a leader in automated multi-omic and synthetic biology solutions, has named William J. Kullback as its Chief Financial Officer, effective August 28, 2023.",RVTY,0.056943,0.041942,Neutral
"Revvity  ( RVTY )  Beats on Q2 Earnings, Lowers '23 EPS View",https://www.zacks.com/stock/news/2131116/revvity-rvty-beats-on-q2-earnings-lowers-23-eps-view,2023-08-02 13:00:00,Revvity's (RVTY) second-quarter results reflect the impact of lower COVID-related sales. Both earnings and sales outpace their respective consensus estimate.,RVTY,0.51278,0.18048,Somewhat-Bullish
Revvity  ( RVTY )  Q2 Earnings and Revenues Top Estimates,https://www.zacks.com/stock/news/2130238/revvity-rvty-q2-earnings-and-revenues-top-estimates,2023-08-01 11:15:06,"Revvity (RVTY) delivered earnings and revenue surprises of 2.54% and 0.56%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?",RVTY,0.401331,0.111755,Neutral
Morning Bid: August cools Wall St stocks,https://www.reuters.com/markets/us/global-markets-view-usa-2023-08-01/,2023-08-01 10:02:00,"A look at the day ahead in U.S. and global markets from Mike Dolan After notching a fifth straight month of gains for July ( .SPX ) , Wall St stocks looked set to step back on Tuesday as a deluge of corporate earnings hit this week and poor manufacturing soundings from around the world set a more ...",RVTY,0.064104,0.074045,Neutral
Revvity  ( RVTY )  to Report Q2 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2129877/revvity-rvty-to-report-q2-earnings-whats-in-the-cards,2023-07-31 12:40:00,"Revvity's (RVTY) second-quarter results are likely to reflect weak performance at the Diagnostics segment, partially offset by strong demand for Life Sciences and Diagnostics franchise.",RVTY,0.421485,0.239061,Somewhat-Bullish
Earnings Preview: Revvity  ( RVTY )  Q2 Earnings Expected to Decline,https://www.zacks.com/stock/news/2126978/earnings-preview-revvity-rvty-q2-earnings-expected-to-decline,2023-07-25 14:01:29,Revvity (RVTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,RVTY,0.259727,0.078994,Neutral
"Accelerated Digitalization Key to Decarbonizing the Chemicals Industry, says MIT Technology Review Insights Report",https://www.newswire.ca/news-releases/accelerated-digitalization-key-to-decarbonizing-the-chemicals-industry-says-mit-technology-review-insights-report-826403691.html,2023-06-27 14:00:00,"CAMBRIDGE, Mass., June 27, 2023 /CNW/ -- A new report by MIT Technology Review Insights explores why focus on accelerated digitalization helps decarbonization and emissions efforts, and drives innovation.",RVTY,0.294682,0.343592,Somewhat-Bullish
Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation - Abcam  ( NASDAQ:ABCM ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/06/32930681/abcam-downgrade-analyst-trims-expectations-amid-activist-investor-engagement-and-po,2023-06-20 18:37:22,"RBC Capital Markets has downgraded Abcam PLC ABCM from Outperform to Sector Perform with a price target of $22, down from $23. The analyst writes that it has always liked Abcam's fundamentals but sees activist investor engagement and anticipation of a potential bid as likely to drive material ...",RVTY,0.31282,0.410289,Bullish
Revvity  ( NYSE:PKI )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/06/19/revvity-nysepki-now-covered-by-stocknews-com.html,2023-06-19 05:18:43,"Analysts at StockNews.com initiated coverage on shares of Revvity ( NYSE:PKI - Get Rating ) in a research report issued to clients and investors on Monday. The firm set a ""hold"" rating on the medical research company's stock. Several other equities research analysts have also commented on the ...",RVTY,0.70374,0.399685,Bullish
Revvity  ( RVTY )  Launches Single Solution for Drug Development,https://www.zacks.com/stock/news/2107749/revvity-rvty-launches-single-solution-for-drug-development,2023-06-13 16:09:00,"Revvity (RVTY) Signals Software suite integrates streamlining data, global monitoring and customizable workflows and covers the entire Make-Test-Decide lifecycle, which can be centrally managed.",RVTY,0.499789,0.385185,Bullish
StockNews.com Initiates Coverage on Revvity  ( NYSE:PKI ) ,https://www.defenseworld.net/2023/06/11/stocknews-com-initiates-coverage-on-revvity-nysepki.html,2023-06-11 05:30:45,"Research analysts at StockNews.com initiated coverage on shares of Revvity ( NYSE:PKI - Get Rating ) in a research note issued on Sunday. The brokerage set a ""hold"" rating on the medical research company's stock. A number of other equities analysts also recently commented on the company.",RVTY,0.764056,0.303744,Somewhat-Bullish
Revvity  ( RVTY )  Launches New System for Autoimmune Diagnostics,https://www.zacks.com/stock/news/2104644/revvity-rvty-launches-new-system-for-autoimmune-diagnostics,2023-06-06 16:37:00,"Revvity's (RVTY) EUROIMMUN launches UNIQO 160, a new automated system for autoimmune disease diagnostics using indirect immunofluorescence test.",RVTY,0.443626,0.151554,Somewhat-Bullish
Revvity  ( NYSE:PKI )  Earns Hold Rating from Analysts at StockNews.com,https://www.defenseworld.net/2023/06/03/revvity-nysepki-earns-hold-rating-from-analysts-at-stocknews-com.html,2023-06-03 05:20:44,Revvity ( NYSE:PKI ) Earns Hold Rating from Analysts at StockNews ... Defense World ...,RVTY,0.762049,0.434995,Bullish
Revvity  ( NYSE:PKI )  Now Covered by Analysts at StockNews.com,https://www.defenseworld.net/2023/05/26/revvity-nysepki-now-covered-by-analysts-at-stocknews-com.html,2023-05-26 05:22:46,"Equities researchers at StockNews.com initiated coverage on shares of Revvity ( NYSE:PKI - Get Rating ) in a research report issued on Friday. The brokerage set a ""hold"" rating on the medical research company's stock.",RVTY,0.781328,0.463785,Bullish
Prioritizing mental health: A blueprint for effective government interventions | The Financial Express,https://www.financialexpress.com/healthcare/prioritizing-mental-health-a-blueprint-for-effective-government-interventions/3096233/,2023-05-21 13:05:00,Prioritizing mental health: A blueprint for effective government ... The Financial Express ...,RVTY,0.028592,0.19972,Somewhat-Bullish
